- Trials with a EudraCT protocol (153)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
153 result(s) found for: Adiponectin.
Displaying page 1 of 8.
| EudraCT Number: 2005-003093-21 | Sponsor Protocol Number: 20091977 | Start Date*: Information not available in EudraCT |
| Sponsor Name:Medical Department I | ||
| Full Title: Influence of combined therapy of niacin and statins on stem cell mobilization and inflammatory parameters in patients suffering from coronary artery disease – randomized clinical study - | ||
| Medical condition: Have stable coronary artery disease (i.e. no acute event like myocardial infarction or PTCA less then 3 months ago) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-003370-26 | Sponsor Protocol Number: CLAF237ADE03 | Start Date*: 2007-11-15 |
| Sponsor Name:Charite Universitätsmedizin Berlin | ||
| Full Title: A prospective, single center, double blind, placebo controlled study of adipocytokines, adipose tissue gene expression and hepatic insulin clearance in the therapeutic response to vildagliptin in man | ||
| Medical condition: This is a single center, randomized, double-blind pilot study on patients with Type 2 diabetes. The purpose of this study is to test the effects of vildagliptin (as add-on to metformin) on hepatic ... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-002084-49 | Sponsor Protocol Number: 06023GM-A | Start Date*: 2006-09-13 |
| Sponsor Name:Belfast City Hospital Trust | ||
| Full Title: Vascular function in impaired glucose tolerance - effect of pioglitazone | ||
| Medical condition: Impaired glucose tolerance | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-004163-39 | Sponsor Protocol Number: HSJD-LIT-05 | Start Date*: 2005-11-14 |
| Sponsor Name:Hospital Sant Joan de Déu | ||
| Full Title: Effects on Endocrine-Metabolic Parameters and Body Composition of the Addition of Low-Dose Pioglitazone to Flutamide-Metformin Therapy in Young Women with Hyperinsulinemic Ovarian Hyperandrogenism ... | ||
| Medical condition: Polycystic Ovary Syndrome includes anovulatory hyperandrogenism, hyperinsulinemia and/or dyslipidemia. Adiponectin and interleukin-6 are adipocytokines that have been related to abdominal fat exces... | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-002102-73 | Sponsor Protocol Number: 171178 | Start Date*: 2012-02-17 | ||||||||||||||||
| Sponsor Name:Endokrinologisk afd. M | ||||||||||||||||||
| Full Title: Testosterone therapy of patients with type 2 diabetes mellitus | ||||||||||||||||||
| Medical condition: Type 2 diabetes mellitus (T2DM) is a common endocrine disorder caracterized by hyperinsulinaemia and insulin resistance. We aim to investigate if testosterone therapy can improve body composition, ... | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||
| Trial protocol: DK (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2005-004021-26 | Sponsor Protocol Number: RRK 2768 | Start Date*: 2005-10-06 |
| Sponsor Name:University Hospital Birmingham | ||
| Full Title: Longitudinal relationship between lipodystrophy and adipocyte mitochondria DNA in HIV Patients: comparison between Efavirenz (Sustiva) plus AZT/3TC (Combivir) and a less mitochrondial DNA-toxic reg... | ||
| Medical condition: HIV | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-016382-29 | Sponsor Protocol Number: P1736-05/34/09 | Start Date*: 2009-11-06 |
| Sponsor Name:Piramal Life Sciences Limited | ||
| Full Title: A Phase II, 12-Week Randomised, Double-Blind, Placebo-Controlled, Proof of Concept Study to Evaluate Safety, Tolerability, Pharmacokinetics and Effect On Glycemic Control of P1736-05 in Subjects wi... | ||
| Medical condition: Diabetes mellitus, type 2 (Blood Glucose Lowering Effect)/ | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) HU (Completed) CZ (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-002758-21 | Sponsor Protocol Number: DTCI-PIT-001 | Start Date*: Information not available in EudraCT |
| Sponsor Name:Innovative Diabetes Treatments Studies LLC | ||
| Full Title: PILOT STUDY FOR EVALUATION OF THE IMPACT OF PULSATILE INSULIN INFUSION THERAPY ON VASCULAR FUNCTION IN PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS | ||
| Medical condition: treatment of long-term effects of Diabetes Type 1 and Type 2 | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-000676-42 | Sponsor Protocol Number: PAP_RI1_2019/1 | Start Date*: 2023-01-24 |
| Sponsor Name:University Center Hospital of Guadeloupe | ||
| Full Title: Efficacy of metformin versus sitagliptin on benign thyroid nodules size in type 2 diabetes: a 2-years prospective multicentric study | ||
| Medical condition: newly diagnosed subjects with uncomplicated T2DM and begnin TN of at least 2 cm of size, after pregnancy exclusion if women | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-004226-28 | Sponsor Protocol Number: ATS K016 | Start Date*: 2005-01-17 |
| Sponsor Name:Takeda Pharma GmbH | ||
| Full Title: Effects of Pioglitazone in Patients with Type 2 Diabetes Mellitus and Coronary Heart Disease at High Risk for Cardiovascular Complications | ||
| Medical condition: Type 2 Diabetes mellitus | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-015523-91 | Sponsor Protocol Number: ENM-EA-011 | Start Date*: 2010-01-21 |
| Sponsor Name:Medizinische Universiätsklinik Graz, Abteilung für Endokrinologie und Nuklearmedizin | ||
| Full Title: Placebo controlled study on effects of vitamin D supplementation in healthy women and men on immunological, endocrine and metabolic parameters | ||
| Medical condition: healthy volunteers. The intended indication for the investigated product is prevention and treatment of immunological (e.g. type 1 diabetes), endocrine (e.g. endocrine hypertension), metabolic (e.g... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-011534-10 | Sponsor Protocol Number: 7798 | Start Date*: 2009-06-23 |
| Sponsor Name:Karolinska University Hospital | ||
| Full Title: Effects on insulin sensitivity and body composition of combination therapy with growth hormone (GH) and insulin-like growth factor-I (IGF-I) in growth hormone deficient adults with impaired glucose... | ||
| Medical condition: To evaluate the effect on glucose sensitivity and body composition of combination therapy with GH and IGF-I in growth hormone deficient adults with impaired glucose tolerance or diabetes. The hypot... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-005698-31 | Sponsor Protocol Number: 4/2005 | Start Date*: 2006-09-12 |
| Sponsor Name:National Medical Center (Országos Gyógyintézeti Központ) | ||
| Full Title: Efficacy of fenofibrate treatment on the insulin sensitivity and pancreas ß-cell function in obese patients with hypertriglyceridemia. | ||
| Medical condition: Patients non-diabetic, obese with hypertriglyceridemia (previously untreated with fibrate). | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: HU (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-001313-14 | Sponsor Protocol Number: 2007-189-2 | Start Date*: 2012-10-17 | |||||||||||
| Sponsor Name:Dutch growth research foundation | |||||||||||||
| Full Title: Young adult Prader-Willi Study Effects of Growth Hormone after final height: A clinical care study to the optimal dosage of growth hormone in young adults with PWS. | |||||||||||||
| Medical condition: Prader Willi Syndrome | |||||||||||||
|
|||||||||||||
| Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2009-013713-99 | Sponsor Protocol Number: 2009.559 | Start Date*: 2010-04-14 | |||||||||||
| Sponsor Name:Hospices Civils de Lyon | |||||||||||||
| Full Title: Does Cyclosporine ImpRove Clinical oUtcome in ST elevation myocardial infarction patients (CIRCUS study) | |||||||||||||
| Medical condition: acute myocardial infarction | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Completed) BE (Completed) ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2019-003907-37 | Sponsor Protocol Number: DON3 | Start Date*: 2020-09-08 | |||||||||||
| Sponsor Name:Università Campus Bio-Medico | |||||||||||||
| Full Title: The effects of vitamin D on bone, muscle and adipose tissue: a phase IV randomized double-blind study. | |||||||||||||
| Medical condition: Obese elderly patients with vitamin D deficiency who have scheduled either hip replacement due to osteoarthritis or bariatric surgery. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2007-000501-29 | Sponsor Protocol Number: CRC-ER-1_2007 | Start Date*: 2008-10-27 | |||||||||||
| Sponsor Name:University Hospital of Erlangen | |||||||||||||
| Full Title: Low grade albuminuria: reaching a new target for irbesartan | |||||||||||||
| Medical condition: low grade albuminuria | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2004-004463-30 | Sponsor Protocol Number: ATS K015 | Start Date*: 2005-06-22 |
| Sponsor Name:Takeda Pharma GmbH | ||
| Full Title: Effects of Pioglitazone in Combination with Atorvastatin in Comparison to Atorvastatin treatment alone on Intima-Media Thickness in patients at Risk for Vascular Complications | ||
| Medical condition: Patients at risk for vascular complications (cardiovascular anamnesis, hypertension, hypercholesterolemia) and a carotid intima media thickness >= 0.8 mm at least at one side will be eligible for t... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-002237-20 | Sponsor Protocol Number: ATS K021 | Start Date*: 2006-08-21 |
| Sponsor Name:Takeda Pharma GmbH | ||
| Full Title: Pilot trial studying the Effects of Pioglitazone in Comparison to Placebo on Myocardial Function and Oxidative Stress in Patients with Type II Diabetes and Insulin Resistance undergoing elective PTCA | ||
| Medical condition: Type 2 diabetic patients treated with oral agents except PPAR gamma agonists and / or patients with insulin resistance measured by IRIS score > 50 with stable coronary artery disease and supposed e... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-004515-56 | Sponsor Protocol Number: hepatology_MT_2007-08 | Start Date*: 2008-04-28 |
| Sponsor Name:Klinische Abteilung für Gastroenterologie und Hepatologie, Medizinische Universitätsklinik, MUG | ||
| Full Title: Efficacy of ursodeoxycholic acid in the treatment of insulin resistance and vascular dysfunction in non-alcoholic fatty liver disease | ||
| Medical condition: Non-alcoholic fatty liver disease (NAFLD) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Prematurely Ended) | ||
| Trial results: View results | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
